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Abstract
Study of Integrin CD11b’s Regulation on Mincle signaling 
Quanri Zhang
Department of Integrated Omics
for Biomedical Science
The Graduate School
Yonsei University
During mycobacteria infection, anti-inflammatory responses allow the host to avoid tissue 
damage caused by overactivation of the immune system; however, little is known about the 
negative modulators that specifically control mycobacteria-induced immune responses. Here, 
we demonstrate that integrin CD11b is a critical negative regulator of mycobacteria cord 
factor-induced macrophage-inducible C-type lectin (Mincle) signaling. CD11b deficiency 
resulted in hyperinflammation following mycobacterial infection. Activation of Mincle by 
mycobacterial components turns on not only the Syk signaling pathway but also CD11b 
signaling, and induces formation of a Mincle-CD11b signaling complex. The activated 
CD11b recruits Lyn, SIRPα, and SHP1, which dephosphorylate Syk to inhibit 
Mincle-mediated inflammation. Furthermore, the Lyn activator MLR1023 effectively 
suppressed Mincle signaling, indicating the possibility of Lyn-mediated control of 
viii
inflammatory responses. These results describe a new role for CD11b in fine-tuning the 
immune response against mycobacterium infection.
Key words: Mycobacteria, CD11b, Mincle, Lyn-Sirpa-Shp1 complex
11. Introduction
The hallmark of Mycobacterium tuberculosis (Mtb) infection is the formation of a 
granuloma, a compact aggregate of immune cells1. The granuloma has been thought to 
function as a host defense mechanism to prevent further spread of Mtb; however, recent 
studies suggest that the granuloma can also shelter the bacteria and ensure persistence of these 
organisms in a latent form2, 3. Therefore, clearance of the mycobacteria that persist in the 
granuloma is required for efficient clearance of the infection.
Granuloma formation is initiated by an orchestrated production of cytokines and 
chemokines coupled with the upregulation of selectins and integrins on immune cells to 
recruit and activate different populations of leukocytes4. As granuloma formation progresses, 
the intense proinflammatory responses are suppressed by negative modulators, to prevent 
excessive granuloma formation5. The most prominent anti-inflammatory cytokine involved in 
the downregulation of granuloma formation is interleukin (IL)-10, which antagonizes the 
activity of IL-17 and interferon (IFN)-γ, thereby lessening the protective immune responses of 
macrophages6, 7 . Additionally, IL-10 may inhibit antigen presentation by dendritic cells 
(DCs) via blockade of major histocompatibility complex molecules8. This compromised 
immune environment may, therefore, enable the bacteria to evade host immune surveillance 
and survive for a long time in the lungs, ultimately leading to a chronic infection. Hence, 
understanding the protective mechanism of negative regulators of granuloma formation will
elucidate key targets for the development of immune therapies to fight Mtb infection.
2Mtb carries diverse pathogen-associated molecular patterns (PAMPs) that can initiate an 
inflammatory response in the host. Among these PAMPs, the virulent cord factor 
trehalose-6,6-dimycolate (TDM) is specifically recognized by macrophage-inducible C-type 
lectin (Mincle), and this cord factor alone leads to a granulomatous response through the 
robust production of nitric oxide (NO) and various proinflammatory cytokines and 
chemokines, including IL-6, tumor necrosis factor (TNF)-α, and monocyte chemoattractant 
protein (MCP)-19, 10, 11. Additionally, TDM stimulation critically enhances the cellular 
adhesion of neutrophils by increasing their surface expression of integrin CD11b/CD1812. 
Amplified integrin surface expression allows neutrophils to infiltrate into and accumulate 
around infected sites, enabling recruitment of additional neutrophils to kill the bacteria. Thus, 
Mincle appears to play a key role in the fight of leukocytes against mycobacteria infection. 
While the activation of the proinflammatory response by Mincle has been studied extensively, 
the negative mediators that specifically restrain Mincle signaling during granuloma formation 
remain to be elucidated.
The integrin heterodimer CD11b/CD18 mainly functions in cell adhesion and migration 
during inflammation13. Intriguingly, recent studies in CD11b-deficient mice suggest a broad 
crosstalk between CD11b and various pattern recognition receptor (PRR)-mediated pathways. 
Specifically, CD11b activated by Toll-like receptor 4 (TLR4) signaling targets Myd88 and 
TIR domain-containing adapter-inducing interferon-β (TRIF) for proteasome degradation, 
thereby negatively regulating the TLR4 signal in peripheral macrophages14. Moreover, 
CD11b can interfere with the function of T and B cells by suppressing the differentiation of 
TH17 cells and inhibiting B cell receptor (BCR) signaling15, 16. Considering that CD11b is 
3upregulated in TDM-activated neutrophils and plays a role in the negative regulation of TLR 
signaling, the relatively static function of macrophages in the granuloma may result from the 
negative regulation of Mincle by CD11b during granuloma formation.
In the present study, we demonstrate that TDM-challenged CD11b-deficient mice 
developed more severe granulomas with increased recruitment of leukocytes and increased 
production of proinflammatory cytokines. In macrophages, the absence of CD11b led to 
increased cytokine production and release of NO and reactive oxygen species (ROS) upon 
TDM stimulation, as well as to enhanced cytokine production against Mycobacterium bovis 
Bacillus Calmette-Guérin (BCG) infection. With respect to neutrophils, CD11b was 
indispensable for adhesion, and CD11b deficiency resulted in increased cytokine levels. We 
found that activated CD11b formed a signaling complex with activated Mincle that recruited 
Lyn kinase, SIRPα, and SHP1; this complex regulated the phosphorylation of the Mincle 
downstream target Syk, thereby suppressing Mincle-dependent inflammatory responses. 
Therefore, CD11b functions as a negative modulator of TDM-Mincle signaling by 
dephosphorylating Syk kinase via the Lyn-SIRPα-SHP1 complex.
42. Materials and methods
2.1. Animals
C57BL/6 mice, aged 6–7 weeks, were purchased from Orient Bio. CD11-/- mice were 
obtained from Jackson Laboratory, and Mincle-/- mice (Clec4eMNA) were obtained from the 
Consortium for Functional Glycomics. The animals were backcrossed for nine generations 
onto the C57BL/6 background. All mice were maintained in a specific pathogen-free facility 
at the Laboratory Animal Research Center at Yonsei University. Protocols were approved by 
the Institutional Animal Care and Use Committees of the Laboratory Animal Research Center 
at Yonsei University (permit number: IACUC-A-201410-317-01).
2.2. Cell culture
BMMs were prepared by culturing BM cells with 20% (v/v) L929 culture supernatant in 
basic Dulbecco’s modified Eagle medium (DMEM; ThermoFisher Scientific) supplemented 
with 20% fetal bovine serum (FBS; Gibco/ThermoFisher Scientific), 50 U/ml penicillin, and 
50 mg/ml streptomycin for 7 days. BMDCs were differentiated by culturing BM cells with 15 
ng/ml recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) in DMEM 
for 10 days. BM neutrophils were purified directly from BM cells by 53/63/76% three-layer 
Percoll gradient centrifugation as described12 and cultured in RPMI basic medium 
supplemented with 10% FBS and penicillin/streptomycin. The iBMM cell line was obtained 
from BEI Resources (no. NR-9456). 
5For TDM stimulation, 50 μg/ml TDM (Sigma) was added to culture plates before cell 
plating. Cells were primed with 10 ng/ml IFN-g (Pierce), 100 ng/ml Pam3CSK4 (InvivoGen), 
and 10 ng/ml ultrapure LPS (InvivoGen) for the indicated times. For the inhibitor assay, the 
indicated inhibitors were added 30 min before stimulation. PP1 (Src family kinase inhibitor, 
529579, 5 μM), PP2 (Src family kinase inhibitor, 529573, 100 nM), Syk Inhibitor (574711, 10 
μM), and SB203580 (559389, 10 μM) were purchased from CalBiochem. AG490 (T3434, 25 
μM) and SP600125 (S5567, 10 μM) were obtained from Sigma. Parthenolide (0610, 5 μM), 
U0126 (1144, 10 μM) and wortmannin (1232, 10 μM) were purchased from Tocris. The Lyn 
activator MLR1023 (4582, 1 ng/ml) was also purchased from Tocris. Fibrinogen from Sigma 
(F3879, 15 mg/ml) was diluted in PBS and coated on plates at 4°C overnight. Then, the
fibrinogen was aspirated and the plate was washed three times with PBS before cell plating.
2.3. ELISA, immunoblot analysis, and immunoprecipitation
IL-6 and TNF-a secretion in culture supernatants was measured using an enzyme-linked 
immunosorbent assay (ELISA) kit (Biolegend). For immunoblot analysis, cells were lysed for 
15 min at 4°C in RIPA lysis buffer (100 mM Tris-HCl, pH 8.0, 50 mM NaCl, 5 mM EDTA, 
0.5% NP-40, 1% Triton X-100, 50 mM b-glycerophosphate, 50 mM NaF, 0.1 mM Na3VO4, 
and 0.5% sodium deoxycholate) with protease inhibitor cocktail (Roche). Following lysis, 
suspensions were centrifuged at 1,300 × g for 15 min at 4°C to remove nuclei. Then, proteins 
were separated by SDS-PAGE and transferred to nitrocellulose membranes. The membranes 
were developed with Amersham enhanced chemiluminescence (ECL) reagents, followed by 
detection of the signal using the ImageQuant LAS 4000 system (GE Healthcare). For 
6immunoprecipitation assays, cells were stimulated with TDM for the indicated times. Then, 
cells were washed and resuspended in NP-40 lysis buffer [50 mM Tris-HCl, pH 7.5, 1 mM 
EGTA, 1 mM EDTA, pH 8.0, 50 mM NaF, 1 mM sodium glycerophosphate, 5 mM 
pyrophosphate, 0.27 M sucrose, 0.5% NP-40, 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 
0.1% 2-mercaptoethanol, 1 mM Na3VO4, and protease inhibitor cocktail (Roche)]. After 
removing nuclei by centrifugation at 1,300 × g for 15 min at 4°C, the cell extracts were 
incubated with V5 agarose or agarose-A beads with Lyn or SHP1 antibodies overnight at 4°C. 
After pull-down, the agarose was washed three times in ice-cold lysis buffer and proteins 
were eluted by boiling in SDS sample buffer. The precipitated proteins were subjected to 
immunoblot analysis as described above. The antibodies used in this study are listed in 
Supplementary Table 1.
2.4. Adhesion assay
Neutrophils (3 × 105 cells/well) were labeled by incubation with 5 µg/ml calcein-
acetoxymethyl ester at 37°C for 30 min, washed with PBS, and resuspended in RPMI medium 
containing 10% FBS. Cells were then plated in 48-well tissue culture plates for TDM 
stimulation. After 6 h of adhesion, non-adherent cells were washed away with PBS aspiration, 
and adherent cells were imaged under a fluorescent microscope. The percentage of adherent 
cells was determined by comparison of fluorescence measured by a microplate reader (Tecan 
Infinite Pro 200) at 492 nm before and after washing.
72.5. ROS assay
ROS production was measured with carboxy-H2DCFDA dye (Molecular Probes). 
Macrophages (3 × 105 cells/well) and neutrophils (1 × 105 cells/well) were seeded in 96-well 
plates and pre-incubated with 10 µM H2DCFDA in PBS for 30 min. After washing in PBS, 
cells were stimulated with TDM. After 6 and 18 h of treatment, oxidized DCFDA was 
analyzed at 495 nm/520 nm using a Multilabel Plate Reader (Victor5, Perkin Elmer). The data 
were normalized to the negative control, which consisted of unchallenged cells.
2.6. NO measurement
NO concentration was measured by classic colorimetric Griess reaction17. Culture 
supernatants were incubated with an equal volume of Griess reagent (Sigma-Aldrich, G4410) 
for 5 min at RT. The absorbance was determined at 570 nm with a Perkin Elmer 550 S 
spectrophotometer. Prepared sodium nitric oxide (1–100 mM) was used to generate a standard 
curve for calculating sample NO concentrations.
2.7. Site-directed mutagenesis
The SHP1 D419A and C453S dominant-negative mutants were constructed using a 
site-directed mutagenesis kit (Stratagene) according to the manufacturer’s instructions. 
Primers used are listed in Supplementary Table 2.
82.8. TDM-induced pulmonary granulomas
To elicit pulmonary granuloma formation, 9–11-week-old mice were injected intravenously 
through the tail vein with 100 µl of a water-in-oil emulsion containing 100 µg of TDM 
(Sigma). On day 7 post-challenge, mice were sacrificed, lungs were weighed, and the LWI 
was calculated as described previously18, 19. A portion of the fresh lung was subjected to flow 
cytometry to assess the leukocyte infiltration just after sacrifice. The large lobe of the right 
lung was fixed in 10% formaldehyde for hematoxylin and eosin staining. Other lung sections 
were homogenized and frozen for future analysis by ELISA or qRT-PCR.
2.9. Air pouch model
Briefly, air pouches were established on the dorsal sides of 9–10-week-old WT and CD11b-/-
mice by subcutaneous injection of 3 ml of sterile air on day 0. A second injection of 1.5 ml of 
sterile air into the pouch was performed on day 3. On day 7, 200 µl of a water-in-oil emulsion 
containing 50 µg of TDM was injected into the pouch cavity, while an emulsion without 
TDM was injected into the control animals. Approximately 24 h after the final injection, mice 
were sacrificed, and the pouch cavities were washed with PBS. The wash fluid was harvested 
for leukocyte population analysis by flow cytometry and cytokine measurement by ELISA.
2.10. Flow cytometric analysis
A portion of the lungs was weighed, incubated in 2 mg/ml collagenase D (Roche) and 40 
U/ml DNase I (Roche), and dispersed by passage through 70 mm mesh. After red blood cell
lysis, viable cells were counted and incubated with fluorescence-conjugated antibodies for 
9labeling. The following specific FACS antibodies (BD Pharmingen) were used: Gr-1 
(RB6-8C5), CD11b (M1/70), Ly6G (1A8), CD3e (145-2C11), and CD19 (1D3). To determine 
CD11b and CD18 expression on neutrophils, purified neutrophils were incubated with 
anti-mouse CD11b (M1/70) and CD18 (C71/16) (BD Pharmingen). After incubation, cells 
were analyzed on a FACS Calibur instrument (BD Biosciences). The isotype control 
antibodies used in this experiment were obtained from BD Pharmingen.
2.11. In situ PLA
Protein-protein interactions were investigated using the Duolink In Situ Red Starter Kit 
(Sigma, DUO92105) according to the manufacturer’s instructions. Immortalized BMMs were 
transfected using Lipofectamine for 24 h, and 1 × 103 cells in 200 µl of medium were seeded 
onto 8-well chamber slides coated with TDM. After 24 h, cells were fixed in 4% 
paraformaldehyde for 15 min. Fluorescence was detected with a LSM 700 (Zeiss) confocal 
microscope, and signal intensities were quantified with Photoshop CS. Antibodies used in the 
PLA assay are listed in Supplementary Table 1.
2.12. CRISPR-Cas9-dependent gene knockout in iBMM cells
For knockout in iBMM cells, single-strand guide RNAs were annealed to form gRNA oligo 
duplexes and then ligated into digested lentiCRISPR v2 vectors (Addgene plasmid #52961; a 
gift from Feng Zhang). Lentivirus was generated by co-transfecting HEK 293FT cells with 
lentiCRISPR v2, psPAX2 (packaging), and pMD2.G (envelope). After 48 h, virus-containing 
supernatants were collected and added onto the iBMM cells along with polybrene (8 µg/ml, 
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Sigma). Cells were selected with puromycin (2 µg/ml), and single-cell colonies were further 
selected by plating in 96-well plates. Gene knockout colonies were validated by immunoblot. 
Colonies that still expressed the target proteins were used as negative control lines.
2.13. BCG infection
Macrophages were seeded in 48-well plates (2.0 × 105 cells/well) and incubated overnight. 
Cells were then infected with BCG at a MOI of 10 for 4 h. Non-internalized bacteria were 
washed away with PBS, and cells were incubated with fresh DMEM. At 24, 48, and 72 h after 
infection, media was collected for the analysis of cytokine levels by ELISA.
2.14. qRT-PCR
Total RNA from cells and tissues was extracted with TRIzol reagent (ThermoFisher 
Scientific) according to the manufacturer’s instructions. Then, cDNA was synthesized using 
SuperScript II reverse transcriptase (ThermoFisher Scientific) with oligo(dT) primers. 
Expression of individual genes was determined by real-time PCR using a Bio-Rad CFX and 
quantified by normalizing to the housekeeping gene Gapdh by the 
change-in-cycling-threshold (ΔΔCT) method. Primers used are listed in Supplementary Table 
2.
2.15. Statistical analysis
Software Prism 6.0 (GraphPad) was used to run unpaired two-tailed t-tests with a 95% 
confidence interval for the calculation of P-values.
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3. Results
3.1. Increased cytokine production against mycobacteria in CD11b-deficient mice
To examine the involvement of the integrin receptor in anti-mycobacterial infection, bone 
marrow-derived macrophages (BMMs) from wild-type (WT), CD11b-deficient (CD11b-/-),
and Mincle-deficient (Mincle-/-) mice were challenged with BCG. BCG infection of WT 
BMMs induced the secretion of high levels of inflammatory cytokines such as IL-6 and 
TNF-α (Fig. 1a); however, Mincle-/- BMMs were defective in the secretion of these cytokines 
in response to BCG treatment, indicating that Mincle is the major PRR that mediates cytokine 
release during BCG infection. By contrast, CD11b deficiency caused hyperinduction of 
inflammatory cytokines in response to BCG treatment, indicating that CD11b exerts an 
inhibitory effect on anti-mycobacterial immune signaling. Because CD11b is known to 
mediate inflammation by regulating leukocyte adhesion20, we asked whether the defective 
cellular adhesion in CD11b-deficient BMMs is responsible for the abnormal production of 
cytokines. To this end, we compared the phagocytosis efficiencies of WT and mutant BMMs 
using fluorescent beads. Interestingly, all BMMs tested exhibited comparable phagocytic 
ability, even in the presence of TDM-coated particles (Fig. 2). Together, these results indicate 
that CD11b deficiency may affect anti-mycobacterial cytokine production via effects on 
signaling rather than cell adhesion.
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3.2. Enhanced TDM-Mincle signaling in CD11b-deficient macrophages
Because TLR signaling is independent of CD11b in BMMs21, the hyperinduction of 
inflammatory cytokines in CD11b-deficient BMMs upon BCG infection appeared to mainly 
be dependent on Mincle, which recognizes the major cell wall component of BCG. Thus, we 
investigated the potential role of CD11b in the direct regulation of Mincle using a 
Mincle-specific ligand, TDM. TDM stimulation caused greater production of IL-6 and TNF-α
in CD11b-/- BMMs than in WT BMMs (Fig. 1b). The disparity between the WT and the 
CD11b-/- phenotype was further increased when the macrophages were primed with IFN-g. 
Therefore, the hyperinflammatory cytokine production in response to BCG in the 
CD11b-deficient BMMs appeared to have resulted from abnormal regulation of the Mincle 
signaling pathway.
To confirm the effect of CD11b deletion on Mincle signaling, we examined the expression 
of key molecules that are specifically regulated by Mincle, such as inducible nitric oxide 
synthase (iNOS) and Cox-222. Indeed, iNOS and Cox-2 were highly expressed in the 
TDM-stimulated CD11b-/- macrophages, while expression of these factors was not detectable 
in the TDM-stimulated WT BMMs. These discrepancies were further increased under 
IFN-g-primed conditions that induced high Mincle expression (Fig. 1c). Consistently, NO and 
NADPH oxidase-dependent ROS were produced at higher levels in CD11b-/- macrophages 
than in WT macrophages upon TDM stimulation (Fig. 1d, e). Measurement of mRNA by 
quantitative reverse transcription-coupled polymerase chain reaction (qRT-PCR) revealed that 
diverse inflammatory cytokines (Il6, Tnf, Il1a, and Il1b), chemokines (Ccl2, Cxcl2, and 
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Cxcl10), and signaling molecules (Nos2 and Mmp3), as well as anti-inflammatory cytokines 
(Il10 and Ifnb), were highly upregulated in the CD11b-/- macrophages (Fig. 3).
To further examine the involvement of CD11b in Mincle signaling, the activation of 
molecules downstream of Mincle was monitored. TDM stimulation induced extracellular 
signal-regulated kinase (Erk)1/2 and spleen tyrosine kinase (Syk) phosphorylation specifically, 
and the activation of these molecules was further enhanced in CD11b-/- BMMs compared with 
WT BMMs (Fig. 1f). To rule out the possibility of Mincle-dependent kinase activation via 
positive feedback due to higher Mincle expression in CD11b-/- macrophages, WT and 
CD11b-/- macrophages were primed with TLR agonists to induce similar levels of Mincle 
expression, as described previously23. Both lipopolysaccharide (LPS) and Pam3, a 
TLR2 agonist, induced a similar level of Mincle protein expression, and both stimuli failed to 
induce Syk or Erk1/2 phosphorylation in the absence of TDM treatment. TDM treatment of 
the primed BMMs, however, activated Syk and Erk1/2 phosphorylation robustly, with 
significantly stronger activation in the CD11b-/- BMMs than in the WT cells (Fig. 4). 
Together, these lines of evidence indicate that CD11b regulates the Mincle pathway 
specifically during mycobacterial infection.
3.3. Hyperinflammatory immune response of CD11b-/- mice following TDM 
stimulation
To examine the inhibitory effect of CD11b on Mincle signaling under physiological 
conditions, WT and CD11b-/- mice were challenged with TDM to induce a lung granuloma 
that mimics mycobacterial infection. Intravenous injection of TDM induced granuloma 
14
formation in both WT and CD11b-/- mice, but TDM induced the formation of more severe 
granulomas in the lungs of the CD11b-deficient mice than in the lungs of the WT mice. The 
relative granuloma area and the lung weight index (LWI), which indicate the severity of the 
inflammation, were higher in the lungs of CD11b-/- mice than in the lungs of the WT control 
group (Fig. 5a, b). The numbers of recruited neutrophils and monocytes were significantly 
elevated in the lungs of CD11b-/- mice, in concert with a slight increase in T and B cells 
compared with the WT mice (Fig. 5c). Reflecting the hyperinflammatory conditions in the 
TDM-stimulated CD11b-/- mice, higher RNA and protein levels of proinflammatory cytokines 
such as TNF-α and IL-6 were detected in lung homogenates from CD11b/- mice (Fig. 5d and
Fig. 6). In addition, qRT-PCR analysis revealed a similar upregulation of inflammatory 
cytokines (Il1a and Il12a), chemokines (Ccl2, Cxcl2, and Cxcl10), and signaling molecules 
(Nos2 and Mmp3) in the lungs of CD11b-deficient mice (Fig. 6). 
To confirm the effect of CD11b on TDM-induced granulomatous tissue formation, the 
inflammatory activity of TDM was assessed in WT and CD11b-/- mice using an air pouch 
model24. Similar to the results obtained with intravenous injection of TDM, we observed 
significantly increased levels of leukocytes and inflammatory cytokines (TNF-α and IL-6) in 
the TDM-stimulated air pouches in CD11b-/- mice compared with WT mice (Fig. 5e-f). Taken 
together, these results indicate that TDM challenge leads to exaggerated inflammatory 
responses in CD11b-/- mice, suggesting that CD11b is required for the downregulation of 
inflammation and granuloma formation induced by Mincle activation.
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3.4. Impaired adhesion but increased TDM signaling in CD11b-/- neutrophils
To determine whether CD11b can inhibit Mincle signaling in other cell types, the 
anti-TDM response was examined in neutrophils derived from WT and CD11b-/- mice. As 
described previously12, TDM stimulation increased the surface expression of CD11b and its 
binding partner CD18 in the WT bone marrow (BM)-derived neutrophils. On the other hand, 
CD11b-deficient BM neutrophils exhibited much less CD18 surface expression than WT BM 
neutrophils, and this expression did not increase following TDM treatment (Fig. 7a). In 
accordance with the increased CD11b/CD18 surface expression, WT BM-derived neutrophils 
showed increased adhesion to a TDM-coated surface, while no apparent cell adhesion was 
observed from the CD11b-/- BM-derived neutrophils (Fig. 7b). Despite the reduced levels of 
adhesion, the secretion of TNF-α and IL-6 was higher in CD11b-/- BM neutrophils than in WT 
BM neutrophils, and cytokine production was further enhanced in the CD11b-/- neutrophils by 
IFN-g treatment (Fig. 7c). To determine whether the altered cytokine production may have 
resulted from an effect of CD11b deficiency on neutrophil survival, apoptosis induced by 
TDM treatment was evaluated in WT and CD11b-/- neutrophils. TDM stimulation increased 
neutrophil apoptosis in WT and CD11b-/- BM neutrophils at a similar rate (Fig. 8a). Taken 
together, these findings demonstrate that CD11b is required for cell adhesion and inhibition of 
cytokine production upon TDM stimulation but does not impact TDM-induced apoptosis in 
neutrophils.
Although CD11b has been shown to be required for the induction of MyD88-dependent 
TLR signaling in DCs21, WT and CD11b-/- DCs stimulated with a synthetic analog of TDM, 
trehalose-6,6-dibehenate (TDB), showed no apparent difference in the secretion of the 
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inflammatory cytokines TNF-α and IL-6 (Fig. 8b). Therefore, CD11b appears to play an 
inhibitory role in Mincle signaling in macrophages and neutrophils specifically.
3.5. CD11b interacts with Mincle specifically upon TDM treatment
As Mincle signaling is negatively regulated by CD11b following TDM stimulation, we 
next examined whether CD11b directly interacts with Mincle and/or its downstream adaptor 
proteins and regulators. Because Syk binds FcRg, which is the adaptor molecule for Mincle25, 
we first examined the association between Mincle and Syk via a proximal ligation assay 
(PLA) in immortalized BMMs (iBMMs) transiently transfected with epitope-tagged Mincle 
and Syk. A PLA with antibodies recognizing the specific epitopes tagged to Mincle and Syk 
revealed a number of strong signals regardless of TDM treatment (Fig. 9a). We next 
examined the interaction of CD11b with Mincle. Although there was no PLA signal between 
Mincle and CD11b under resting conditions, the number of interaction signals dramatically 
increased following TDM stimulation. In addition, no binding between CD11b and Mincle 
was observed following LPS stimulation, demonstrating that TDM specifically induced their 
interaction (Fig. 9b).
Stimulation of integrins by fibrinogen is known to initiate a strong outside-in activation 
signal, including the binding of talin to integrin26. We asked whether the TDM-dependent 
binding of Mincle to CD11b also activates CD11b in macrophages. To this end, the 
interaction between the CD11b/CD18 heterodimer and talin on iBMMs after treatment with 
fibrinogen or TDM was examined by PLA. Under basal conditions, no interaction between 
CD11b/CD18 and talin was observed; however, TDM treatment induced strong binding, 
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similar to the effects of fibrinogen treatment on CD11b/CD18 and talin (Fig. 9c). Intriguingly, 
these interactions required functional CD11b/CD18 heterodimers, as CD11b deficiency 
disrupted the interaction between CD18 and talin upon stimulation with TDM or fibrinogen. 
These results indicate that Mincle signaling triggers CD11b/CD18 integrin activation in 
macrophages; the activated integrin receptors then downregulate Mincle signaling through a
direct interaction.
3.6. Activated CD11b attenuates Mincle signaling via Lyn kinase
To understand the regulatory role of CD11b in Mincle signaling, BMMs were treated with 
inhibitors of various signaling pathways and TDM-induced secretion of IL-6 was examined. 
Inhibitors of Syk, Erk1/2 (U0126), and IKK (parthenolide) abolished TDM-induced IL-6 
cytokine production completely, demonstrating their involvement in Mincle-dependent IL-6 
production. Interestingly, treatment with Src family tyrosine kinase (SFK) inhibitors (PP1 and 
PP2) actually increased IL-6 production after TDM stimulation, consistent with the 
upregulation observed in TDM-stimulated CD11b-deficient macrophages (Fig. 10a). 
Mincle-dependent Syk and Erk1/2 phosphorylation was also highly enhanced in PP1-treated 
macrophages upon TDM stimulation (Fig. 10b). Similarly, PP1 treatment resulted in 
increased IL-6 production in neutrophils, but impaired cell adhesion, as described previously12
(Fig. 10c, d). These results indicate that both Mincle-dependent cell adhesion and cytokine 
production are regulated by SFKs. To identify which SFKs were targeted by PP1 under the 
conditions described above, the expression of various SFKs was examined in TDM-treated 
WT and CD11b-/- macrophages by qRT-PCR. Among the nine SFKs examined, Fgr, Hck, and 
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Lyn were induced in WT macrophages by TDM treatment, and Lyn was strongly increased in 
CD11b-/- macrophages (Fig. 10e). Furthermore, treatment of neutrophils with a Lyn-specific 
inhibitor increased their IL-6 production significantly, without impairing cell adhesion (Fig. 
10c, d). These results suggest that Lyn kinase is the SFK primarily mediating the inhibitory 
effect of CD11b signaling against Mincle-dependent proinflammatory cytokine production.
To confirm the role of Lyn in Mincle-mediated signaling, Lyn was knocked out in iBMMs 
using the Cas9/CRISPR system (Fig. 11a). Compared with WT iBMMs, Lyn-/- iBMMs 
showed enhanced Syk and Erk1/2 phosphorylation and stronger induction of proinflammatory 
genes, including Tnf, Il6, Ccl2, Cxcl2, and Nos2, upon TDM stimulation (Fig. 11b and Fig. 
12). Together, these results suggest that CD11b regulates the Mincle pathway through the Lyn 
kinase.
3.7. TDM-dependent binding of Lyn with CD11b, Mincle, and SHP1
Next, the association between Lyn and CD11b in macrophages was examined. Although no 
interaction was observed between CD11b and Lyn under basal conditions, TDM stimulation 
strongly induced this interaction (Fig. 13 a). Consistent with the TDM-dependent binding of 
Mincle to CD11b, Lyn and Syk also exhibited TDM-dependent binding to CD11b (Fig. 13a). 
Therefore, TDM stimulation appears to induce the formation of a receptor complex that 
includes Mincle, CD11b, and their interacting adaptors and kinases.
Previous studies revealed that the repressive role of the tyrosine kinase Lyn mainly relies 
on the recruitment of inhibitory phosphatases such as SH2 domain-containing phosphatase 1 
(SHP1), SHP2, and SH2 domain-containing 5’-inositol phosphatase (SHIP1)27. PLAs were 
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performed before and after TDM treatment to identify the specific interacting phosphatase(s) 
of Lyn in response to TDM stimulation. Among the three phosphatases tested, only SHP1 
interacted with Lyn and Syk specifically upon TDM treatment (Fig. 13b, c). These 
interactions appeared to be dependent on CD11b, in that no such interaction was detected in 
CD11b-deficient cells. In addition, the TDM-dependent Syk-SHP1 interaction was defective 
in Lyn-/- iBMMs. These results indicate that activated Mincle induces formation of an adaptor 
complex with CD11b signaling molecules. 
We next tested whether the phosphatase activity of SHP1 is required for the 
downregulation of Mincle signaling, particularly the Syk phosphorylation. To this end, the 
Mincle/CD11b receptor complex was reconstituted in human embryonic kidney 293 
(HEK293) cells by co-transfecting expression constructs for Mincle, FcRg, Syk, and either 
WT or dominant-negative SHP1 (D419A and C453S). In the reconstituted cells, TDM 
treatment induced Syk phosphorylation, which was diminished significantly by the addition of 
functional SHP1 (Fig. 13d). The dominant-negative forms of SHP1, however, failed to 
dephosphorylate Syk. Therefore, recruitment of SHP1 by activated CD11b dephosphorylates 
Syk, resulting in the inhibition of Mincle signaling.
3.8. SIRPa is critical for the SHP1 recruitment
SHP1 phosphatase recruitment normally requires immunoreceptor tyrosine-based 
inhibitory motif (ITIM)-containing receptors to serve as docking sites. The two 
ITIM-containing receptors Pirb and SIRPa have been studied extensively in association with 
SHP128, 29. To determine which receptor can associate with SHP1 and Lyn upon TDM 
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stimulation, a PLA assay was performed. Pirb exhibited strong binding with CD11b, Syk, Lyn, 
and SHP1 independently of TDM treatment (Fig. 14 a); however, no interaction signal was 
observed for Pirb with Mincle even in the presence of TDM stimulation. These results
indicate that Pirb may interact with SHP1 but that this interaction is not related to the Mincle 
signaling pathway. On the other hand, although SIRPa did not interact with any of the 
Mincle/CD11b receptor complex components tested under resting conditions, this receptor 
produced strong PLA signals with CD11b, Syk, Lyn, SHP1, and Mincle upon TDM 
stimulation (Fig. 14b). In addition, binding of SIRPa to the CD11b/Mincle complex was 
nearly completely disrupted in Lyn-/- and Syk-/- iBMMs (Fig. 15). Therefore, SIRPa appears 
to be a member of the Mincle/CD11b receptor complex.
To investigate the requirement of SIRPa for the regulation of Mincle signaling, 
SIRPa-deficient iBMM cell lines were generated and evaluated for their response to TDM 
challenge (Fig. 16a). Phosphorylation of Syk and Erk1/2 in response to TDM stimulation was 
preserved in SIRPa-/- cells (Fig. 16b). In addition, SIRPa-/- cells secreted more TNF-a and 
IL-6 and had stronger induction of proinflammatory genes (Tnf, Il6, Il1a, Ccl2, and Il12b)
than WT cells (Fig. 16c and Fig. 12). Furthermore, the Lyn-SHP1 interaction was also 
disrupted in SIRPa-/- iBMMs (Fig. 6b), suggesting that SIRPa was required for 
CD11b-mediated negative regulation of Mincle signaling. 
To examine the physiological relevance of the iBMM-based analysis system, rescue 
experiments were performed for CD11b and Syk in iBMM cell lines with deletions of the 
corresponding genes. CD11b-deficient iBMMs showed enhanced Mincle-dependent IL-6 
production, as did the CD11b-/- BMMs, while transfection with Flag-tagged CD11b reduced 
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the Mincle signal. In addition, Mincle signaling was almost completely abrogated in the 
Syk-deficient iBMMs, but transfection with Flag-tagged Syk rescued Mincle-dependent IL-6 
production in those cells (Fig. 17). 
3.9. CD11b initiates the formation of an inhibitory complex to bind Mincle
To confirm the physical interaction between CD11b and Mincle, a co-immunoprecipitation 
assay was performed using iBMMs expressing an epitope-tagged Mincle. 
Immunoprecipitation of Mincle did not pull down CD11b in the absence of TDM treatment. 
However, the amount of CD11b, Syk, and SHP1 that co-immunoprecipitated with Mincle 
gradually increased after TDM stimulation (Fig. 18a). These interactions appear specific to 
TDM stimulation, as no such binding was observed when LPS was used instead of TDM (Fig. 
18b). The interactions among the signaling molecules were further validated using 
endogenous proteins. Pull-down of Lyn in WT macrophages revealed a TDM-dependent 
complex containing Lyn, CD11b, SHP1, and Syk that was disrupted in CD11b-deficient 
macrophages (Fig. 18c,d). Moreover, immunoprecipitation with an anti-SHP1 antibody also 
revealed a TDM- and CD11b-dependent interaction among CD11b, Syk, and SHP1 (Fig. 
18e,f). Taken together with the PLA results, these data confirm the formation of an inhibitory 
complex that contains Lyn, Syk, and SHP1 and binds CD11b and Mincle.
3.10. The Lyn activator MLR1023 suppresses Mincle signaling
Because Lyn plays a pivotal role in the CD11b-mediated negative regulation of Mincle 
signaling, the ability of the Lyn kinase activator MLR1023 to enhance anti-Mincle activity 
was examined. Contrary to the stimulatory effect of PP1 on TDM-induced proinflammatory 
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cytokine production (Fig. 10a), treatment with MLR1023 arrested TDM-induced IL-6 
production in WT macrophages and restored the hyperinflammatory response of CD11b-/-
macrophages to levels similar to those seen in WT macrophages (Fig. 19a). Furthermore, 
MLR1023 treatment reduced the TDM-dependent phosphorylation of Syk and Erk1/2 in both 
WT and CD11b-/- BMMs (Fig. 19b). These results confirmed the negative regulatory role of 
Lyn in Mincle signaling.
To examine the physiological relevance of CD11b-mediated inhibition of 
Mincle-dependent inflammation, the effect of enhanced CD11b signaling on TDM-induced 
granuloma formation in mice was investigated. The Lyn activator MLR1023 was 
administered to TDM-challenged mice and the effects on TDM-induced granuloma formation 
were examined. Compared with the control group, MLR1023-treated mice exhibited less 
severe TDM-induced lung granulomas and lung swelling (Fig. 19c, d). Leukocyte recruitment 
to the lung (Fig. 19e) and TNF-a and IL-6 production (Fig. 19f) were also decreased in the 
MLR1023-treated mice, indicating that MLR1023 suppresses TDM-induced inflammation. 
Intriguingly, MLR1023 treatment also decreased the TDM-induced granuloma response in 
CD11b-/- mice (Fig. 20), confirming the epistatic effect of Lyn in the CD11b signaling 
pathway. Therefore, CD11b signaling plays an important inhibitory role in the regulation of 
Mincle-dependent inflammatory responses against mycobacterial infection. These data 
suggest that the Lyn kinase may be an effective target for the treatment of the excessive 
inflammatory response caused by this infection.
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4. Discussion
Mincle plays a central role in the host defense against mycobacterial infection 
as the major receptor for mycobacterial cell wall component TDM. The activating 
role of this signaling molecule in the proinflammatory response has been well 
studied; however, little is known about the mechanism that leads to dampening of 
this inflammatory signal. In this study, we provide multiple lines of evidence 
demonstrating that CD11b is the crucial negative regulator of Mincle signaling 
and therefore plays an important role in Mtb infection.
First of all, our observation that CD11b deficiency resulted in a significantly 
enhanced Mincle-dependent inflammatory response against TDM and BCG 
challenge extends the function of CD11b in Mtb infection. Phagocytes from 
patients with tuberculosis possess augmented CD11b/CD18 expression, which is 
thought to promote cell adhesion and accumulation at the infection site30. During 
Mtb infection, the immune response is mediated by TLRs, which are activated by 
various molecular patterns on Mtb31. Recent work revealed that CD11b facilitates 
proteasomal degradation of Myd88 and TRIF upon TLR3, 4, and 9 activation, 
thereby inhibiting the inflammatory response14. Yi Bang also reported that CD11b 
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downregulates DC-mediated cross-priming through miR-146a32. Here, we 
demonstrated that CD11b interferes with the proinflammatory response induced 
by the Mtb-specific PAMP TDM and confirmed that live Mtb infection also 
induces increased cytokine production in CD11b-/- BMMs. Although TLR and
Mincle signaling are negatively regulated by CD11b through different 
mechanisms, these signals converge on nuclear transcription factor-kappaB 
(NF-κB) and synergistically enhance the inflammatory response toward Mtb 
infection33, 34. Altogether, CD11b appears to play a broad role in the negative 
regulation of the proinflammatory response toward PAMPs expressed by Mtb.
Moreover, CD11b may be involved in inflammatory responses toward Mtb 
infection via another Mincle ligand. During the late phase of Mtb infection, 
infected macrophages are cleared by apoptosis, necrosis, and autophagy35. 
Necrotic cell death results in the release of spliceosome-associated protein 130 
(SAP130), a soluble component of the U2 small nuclear ribo-
nucleoprotein-associated protein that is normally found in the nucleus36. 
Yamasaki et al. reported that ligation of SAP130 to Mincle on macrophages also 
elicits proinflammatory responses through FcRg and Card9, similar to the effects 
of TDM stimulation25. Hence, these findings indicate that CD11b may further 
regulate the immune response during the late stage of Mtb infection through 
SAP130-mediated Mincle signaling.
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Secondly, our results indicate that negative regulation of Mincle signaling by 
CD11b occurs via the Lyn kinase. As an SFK, Lyn plays both positive and 
negative roles in modulating immune function and is also associated with 
integrin-mediated cellular homeostasis37. Lyn provides a positive signal via 
phosphorylation of ITAM-carrying proteins, such as FcRg, to recruit Syk and 
activate Syk-mediated signaling38. Conversely, Lyn can downregulate signaling 
via direct interactions with a target protein like interferon regulatory factor (IRF) 
5. Lyn ultimately inhibits IRF5 ubiquitination and phosphorylation, impairing the 
IRF5-mediated TLR-Myd88 signal39. Meanwhile, the main negative regulatory 
role of Lyn is dependent on the recruitment of phosphatases such as SHP1, SHP2, 
and SHIP1, which target proteins through ITIM domain-carrying receptors such 
as SIRPa and Pirb. Here, we found that Lyn interacts with CD11b in a Mincle 
signaling-dependent manner. Following inhibition of Lyn with PP1 in BMMs or 
deletion of Lyn in iBMMs, we observed a hyper-response toward TDM 
stimulation similar to that observed in CD11b-/- cells following TDM stimulation. 
The negative regulatory role of Lyn has been thoroughly investigated within the 
context of BCR signaling and integrin-mediated adhesion. Recent work defined 
CD11b as the major modulator in the formation of the inhibitory complex 
Lyn-CD22-SHP1, which restrains BCR signals16. In addition, Lyn-/- macrophages 
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display decreased activation of SIRPa, Pirb, and SHP1 upon growth factor 
stimulation, suggesting that Lyn, SIRPa/Pirb, and SHP1 may function together to 
exert negative regulatory effects in response to growth factors40. Similar to these 
findings, we found that Lyn dephosphorylates Syk, a target previously known to 
be positively regulated by Lyn. This dephosphorylation was mediated by Lyn’s 
recruitment of SHP1 to the docking protein SIRPa in a CD11b-dependent 
manner.
Treatment of cells with PP1 during TDM stimulation revealed a broad role for 
SKFs in Mincle signaling. Integrin activation can be more easily studied in 
neutrophils than in macrophages, as robust functional readouts exist for these 
cells41. Upon integrin activation, neutrophils show greatly enhanced adhesion. 
TDM stimulation facilitated adhesion in neutrophils, which was abrogated by PP1 
treatment or CD11b deficiency, but not by inhibition of Lyn. These results suggest 
that CD11b plays a major role in TDM-induced neutrophil adhesion, while SFKs 
besides Lyn could positively modulate this process. On the other hand, utilizing a 
Lyn-specific inhibitor led to enhanced cytokine production in neutrophils, with no 
influence on cell adhesion. These findings are consistent with our predicted model, 
in which Lyn is critical for the formation of an inhibitory complex that is 
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dependent on signals transduced by activated CD11b, but does not affect 
CD11b-mediated adhesion induced by TDM. 
In addition, treatment with the Lyn activator MLR1023 inhibited Mincle 
signaling both in vitro and in vivo. MLR1023 is a selective Lyn activator and a 
potential insulin sensitizer that was developed as a candidate therapeutic drug for 
type II diabetes42. Interestingly, enhanced Mincle expression was detected in 
obesity-induced adipose tissue fibrosis, suggesting that augmented Mincle 
signaling may contribute to adipose tissue fibrosis formation and thereby promote 
obesity43. Fibrosis is a similar process to granuloma formation and involves the 
accumulation of activated macrophages that highly express CD11b44, 45. In our 
granuloma model, treatment of TDM-challenged mice with MLR1023 decreased 
Mincle signaling and inhibited granuloma formation. Therefore, MLR1023 
treatment of obese mice may also decrease adipose fibrosis formation by 
inhibiting Mincle signaling. Recently, Lee and colleagues found that enhanced 
Mincle signaling is strongly correlated with uveitis, an autoimmune disease of the 
eye46. Thus, further studies might be warranted to determine whether treatment 
with MLR1023 could inhibit Mincle signaling in these Mincle-related diseases.
Finally, regulation of CD11b in TDM-Mincle signaling specifically affects 
macrophages and neutrophils, but not DCs. Although CD11b is as highly 
expressed in DCs as in macrophages47, its function might vary in different cell 
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types, even in response to the same stimulation. For example, in the context of 
LPS stimulation, CD11b exerts a negative role in macrophages by facilitating the 
degradation of Myd88 and TRIF14, but positively influences LPS signaling in 
DCs21. Meanwhile, SHP1 has also been reported to form an inhibitory axis 
following activation by Mincle signaling in DCs; this results in reduced adaptive 
immunity to Leishmania major infection48. However, in that paper, TDB was not 
the inducer of the Mincle-SHP1 interaction in DCs. Therefore, the 
Lyn-SIRPα-SHP1 inhibitory complex may be formed specifically in response to 
Mincle signaling in macrophages and neutrophils.
Similarly, Lyn and SIRPα were observed to have opposing effects in deficient 
iBMMs, which might be explained by the multiple biological functions of Lyn 
and SIRPa. Lyn is particularly well-known as a dual functional regulator in 
macrophages, where it negatively regulates signaling induced by growth factors 
and integrin activation37. Some studies have also implicated Lyn activation 
particularly in signaling through the IL-3 and IL-6 receptors49. Meanwhile, SIRPa
can bind to and be activated by the transmembrane protein CD47, which is 
expressed on immortalized cell lines like the iBMMs that were used in this study50. 
SIRPa-CD47 binding can induce a variety of signaling pathways that result in the 
inhibition of phagocytosis51. Also, SIRPa expressed on macrophages can 
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attenuate mitogen-activated protein kinase (MAPK) signaling and NF-κB 
activation in response to LPS treatment through an association with SHP252. 
Considering that both Lyn and SIRPa could specifically regulate the production 
of distinct cytokines via divergent pathways, a deficiency in either Lyn or SIRPa
may have a distinct influence on the major inhibitory function of CD11b-SHP1 in 
Mincle signaling. 
In conclusion, we demonstrated that activation of CD11b in response to TDM 
acts as a critical negative regulator of Mincle signaling by promoting formation of 
a Lyn-SIRPa-SHP1 complex that dephosphorylates Syk. CD11b deficiency led to 
a hyper-response against TDM challenge, while Lyn activation by MLR1023 
exerted the opposite effect and impaired the TDM-induced inflammatory response. 
Our results provide insight into the mechanisms involved in fine-tuning Mincle 
signaling during the inflammatory response and suggest Lyn as a potential target 
for modulation of the immune response during Mtb infection.
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Figure 1. CD11b deficiency enhances the macrophage response to BCG infection and 
TDM stimulation.
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- continued Figure 1.
Figure 1. CD11b deficiency enhances the macrophage response to BCG 
infection and TDM stimulation.
(a) BMMs from WT, CD11b-/-, and Mincle-/- mice were infected with BCG at a 
MOI of 5, and the cell culture supernatants were collected at the indicated time 
points. Secreted cytokines (IL-6 and TNF-α) were assayed with ELISA. (b-d) WT 
and CD11b-/- BMMs were stimulated with 10 ng/ml IFNg or 50 µg/ml TDM or 
co-stimulated with TDM and IFNg (I+T) for 24 h. (b) IL-6 and TNF-a cytokine 
levels from culture media were determined by ELISA. (c) Expression levels of 
iNOS, Cox-2, and total protein were determined by western blot. (d) NO 
generated in the cell supernatant was measured using the Griess reagent. (e) 
Induction of ROS was determined using the H2DCFDA assay 6 and 18 h after 
stimulation with 50 µg/ml TDM. (f) Phosphorylation of Syk and Erk kinases in 
WT and CD11b-/- BMMs was analyzed by immunoblot at the indicated times.
b-actin protein level was used as loading control in western blot assay. Data are 
representative of at least three independent experiments. *P<0.05, **P<0.01, 
***P<0.0001 (two-tailed unpaired Student’s t-test).
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Figure 2. Phagocytosis of GFP- and TDM-labelled beads was not altered in 
BMMs from WT, CD11b-/-, or Mincle-/- mice.
Figure 2. Phagocytosis of GFP- and TDM-labelled beads was not altered in 
BMMs from WT, CD11b-/-, or Mincle-/- mice.
Macrophages from WT, CD11b-/-, and Mincle-/- mice were plated and incubated 
overnight, and GFP-labelled or TDM-coated latex beads were added to the culture. 
Cells were collected at the indicated times, and internalization of the beads was 
analyzed with flow cytometry. Data are representative of three independent 
experiments.
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Figure 3. Enhanced proinflammatory gene expression in CD11b -/- BMM 
upon TDM stimulation.
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Figure 3. Enhanced proinflammatory gene expression in CD11b -/- BMM 
upon TDM stimulation.
Relative mRNA expression of proinflammatory genes was quantified in WT and 
CD11b-/- BMM treated with TDM (50 mg/ml) for the indicated times. Data are 
representative of three independent experiments. *P<0.05, **P<0.01, 
***P<0.0001 (two-tailed unpaired Student’s t-test).
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Figure 4. Mincle downstream signal activation in LPS- or Pam3-primed, 
TDM-simulated WT and CD11b-/- macrophages.
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Figure 4. Mincle downstream signal activation in LPS- or Pam3-primed, 
TDM-simulated WT and CD11b-/- macrophages.
Macrophages from WT and CD11b-/- mice were pretreated with (10 ng/ml) LPS or 
(100 ng/ml) Pam3 for 3 h and then challenged with TDM for the indicated times. 
Total protein and phosphorylated Syk and Erk were analyzed by immunoblot 
assay. b-actin protein expression was used as loading control in western blot assay. 
Data are representative of two independent experiments.
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Figure 5. Absence of CD11b leads to more severe granuloma formation and 
hyperrecruitment of inflammatory cells in vivo.
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- continued Figure 5.
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Figure 5. Absence of CD11b leads to more severe granuloma formation and 
hyperrecruitment of inflammatory cells in vivo.
(a-d) WT and CD11b KO mice (n=8) were intravenously injected with (3.75
mg/kg) TDM in an oil-in-water emulsion and sacrificed at 7 d post-TDM 
challenge. (a) Lungs were isolated and stained with hematoxylin and eosin (H&E) 
for histology analysis after measurement of lung weight for lung weight index 
(LWI) calculations shown in (b). Scale bars, 100 mm. (c) Flow cytometry was 
performed for leukocyte subset analysis with distinct markers for monocytes and 
macrophages (Mo/Ma, CD11b+ Ly6G-), neutrophils (PMN CD11b+ Ly6G+), T 
cells (CD3+), and B cells (CD19+). (d) The lung homogenates were analyzed by 
ELISA for IL-6 and TNF-a production. (e-f) For the air pouch model, mice (n=8) 
were dorsolaterally injected with sterile air on day 0 and day 3 followed by 
injection of 2.5 mg/kg TDM emulsion on day 7. Then on day 8, (e)wash fluid 
from the pouches were assessed by flow cytometry for leukocyte subsets as 
described above. (f)The IL-6 and TNF-a cytokine levels were determined by 
ELISA. *P<0.05, **P<0.01, ***P<0.0001 (two-tailed unpaired Student’s t-test). 
Data are representative of two independent experiments. (b-f, mean and s.d. of 8 
mice per group).
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Figure 6. Induction of proinflammatory genes in the lungs of TDM-treated 
WT and CD11b-/- mice.
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Figure 6. Induction of proinflammatory genes in the lungs of TDM-treated 
WT and CD11b-/- mice.
Relative mRNA expression of proinflammatory genes in lung homogenates from 
TDM-challenged WT and CD11b-/- mice lung were quantified by qRT-PCR and 
normalized to Gapdh. Data are representative of two independent experiments. 
*P<0.05 (two-tailed unpaired Student’s t-test). 
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Figure 7. CD11b-deficient neutrophils exhibit impaired adhesion but 
increased activity upon Mincle activation.
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- continued Figure 7.
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Figure 7. CD11b-deficient neutrophils exhibit impaired adhesion but 
increased activity upon Mincle activation.
(a) Bone marrow (BM) neutrophils from CD11b WT and KO mice were treated 
with 50 µg/ml TDM, and surface expression of CD11b and CD18 was determined 
by flow cytometry 24 h after stimulation. (b) WT and CD11b-/- BM neutrophils 
were pre-labeled with calcein acetoxymethyl ester 6 h before 50 µg/ml TDM 
treatment with or without priming with 10 ng/ml IFNg (I+T). Adhered cells were 
imaged with fluorescent microscope (bottom panel, 40×). The percentage of 
adherent cells was determined by comparison of fluorescence measured by a 
microplate reader at 492 nm before and after washing(b top panel). (c)IL-6 and 
TNF-a levels were assayed 24 h after TDM stimulation. Data are representative 
of three independent experiments. *P<0.05, **P<0.01, ***P<0.0001 (two-tailed 
unpaired Student’s t-test).
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Figure 8. Comparison of neutrophil apoptosis and dendritic cell cytokine 
production upon activation of Mincle signaling in WT and CD11b-/- cells. 
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Figure 8. Comparison of neutrophil apoptosis and dendritic cell cytokine 
production upon activation of Mincle signaling in WT and CD11b-/- cells. 
(a) WT and CD11b-/- neutrophils were treated with TDM (50 µg/ml) for 24 h. 
Cells were labeled with Annexin V and propidium iodide (PI) and analyzed by 
flow cytometry. (b) WT and CD11b-/- BMDCs were stimulated with TDM for 24 
h, and the levels of TNF-α and IL-6 in the cell culture supernatants were measured 
by ELISA. Data are representative of three independent experiments. No 
significant differences were observed (P>0.05).
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Figure 9. CD11b specifically interacts with Mincle upon TDM treatment
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- continued Figure 9.
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Figure 9. CD11b specifically interacts with Mincle upon TDM treatment.
iBMM cells were transfected with indicated tagged-plasmids. (a) PLA was 
performed for detection of Mincle-CD11b and Mincle-Syk interactions in iBMMs 
that were stimulated with TDM for 12 h. (b) The Mincle-CD11b interactions 
following stimulation with TDM (50 µg/ml) for 12 h or LPS (100 ng/ml) for 6 h 
were compared. (c) Interactions of CD11b/CD18 with endogenous talin in WT 
and CD11b-/- iBMM cells were examined after stimulation with TDM (50 µg/ml) 
for 24 h or fibrinogen (1 mg/ml) for 30 min. Interactions were visualized as 
fluorescent spots (red, PLA signal), and nuclei were stained with DAPI (blue). 
The number of PLA signals was determined for at least 50 cells for each condition. 
Data are representative of three independent experiments. **P<0.01, 
***P<0.0001 (two-tailed unpaired Student’s t-test).
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Figure 10. Lyn inhibits Mincle signaling by interfering with Mincle 
downstream target.
53
- continued Figure 10.
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Figure 10. Lyn inhibits Mincle signaling by interfering with Mincle 
downstream target.
(a) IL-6 cytokine production in the culture supernatants from WT BMMs that 
were treated with TDM and the indicated inhibitors for 24 h was measured by 
ELISA. (b) Syk and Erk kinase activation in WT BMM that were treated with 
TDM and either DMSO or PP1 for 6 h were analyzed by western blot. (c) WT and 
CD11b-/- BMMs were stimulated with TDM for 24 h, and then the mRNA levels 
of Src family kinases (SFK) were quantified by qRT-PCR. (d) Knockout of Lyn in 
iBMMs was confirmed using western blot (right panel). WT and Lyn-knockout 
iBMMs were stimulated with TDM. After 24 h of stimulation, cytokine 
production of IL-6 and TNF-a was detected by ELISA. (e) Phosphorylation of 
Syk and Erk after 0, 3, or 24 h of TDM stimulation was compared by western blot 
assay. b-actin protein expression was used as loading control in western blot assay
Data are representative of at least three (a, c and e upper panel) or two (b, d and e
lower panle) independent experiments. *P<0.05, **P<0.01, ***P<0.0001 
(two-tailed unpaired Student’s t-test).
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Figure 11. Enhanced Mincle signaling and cytokine production in Lyn-/-
iBMMs.
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Figure 11. Enhanced Mincle signaling and cytokine production in Lyn-/-
iBMMs.
(a) Knockout of Lyn in iBMMs was confirmed by western blot. WT and Lyn-/-
iBMMs were stimulated with TDM. (b) After 24 h of stimulation, levels of IL-6
and TNF-a were determined by ELISA. (c) Phosphorylation of Syk and Erk after 
0, 3, or 24 h of TDM stimulation was evaluated by western blot. b-actin protein 
expression was used as a loading control. Data are representative of at least three 
(c) or two (a and b) independent experiments. *P<0.05 (two-tailed unpaired 
Student’s t-test).
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Figure 12. Induction of proinflammatory genes in WT, Lyn-/- and Sirpa-/-
iBMMs upon TDM stimulation.
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Figure 12. Induction of proinflammatory genes in WT, Lyn-/- and Sirpa-/-
iBMMs upon TDM stimulation.
Quantitative PCR was performed on WT, Lyn-/-, and Sirpa-/- iBMMs that were 
treated with TDM for the indicated times. Results were normalized to Gapdh
expression. Data are representative of three independent experiments. *P<0.05, 
**P<0.01 (two-tailed unpaired Student’s t-test).
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Figure 13. Lyn recruits Shp1 to dephosphorylate Syk.
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- continued Figure 13.
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- continued Figure 13.
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Figure 13. Lyn recruits Shp1 to dephosphorylate Syk.
iBMMs were transfected with Flag-CD11b and HA-Lyn or, HA-Lyn and 
Flag-Syk for (a), HA-lyn and Myc-Shp1 or Myc-Shp2 or Myc-Ship1 for (b), 
Flag-Syk and Myc-Shp1 or Myc-Shp2 or Myc-Ship1 for (c) for 24 h, followed by 
stimulation with TDM for 12 h before assessed with the PLA assay. (a) 
Interaction of Lyn to CD11b or Syk was measured by PLA assay. (b and c) 
Specific binding of Lyn and Syk to Shp1, Shp2, and Ship1 in iBMMs was 
examined. Interactions were visualized as fluorescent spots (Red, PLA signal), 
nuclei were stained with DAPI (blue), and the number of PLA signals was
determined for at least 50 cells for each condition. (d) Immunoblot analysis of 
293T cells that were transiently transfected with V5-Mincle, Myc-FcRg, Flag-Syk 
together with Flag tagged WT or phosphatase-inactive Shp-1 (C453S or D419A)
for 24 h. Cells were then treated with or without TDM for 6 h. Data are 
representative of three independent experiments. ***P<0.0001 (two-tailed 
unpaired Student’s t-test).
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Figure 14. ITIM motif-containing Sirpα is critical for Shp1 docking and 
interaction with Syk
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Figure 14. ITIM motif-containing Sirpα is critical for Shp1 docking and 
interaction with Syk
(a) iBMM cells were transfected with one of Flag-CD11b, Flag-Syk, V5-Mincle, 
HA-Lyn, Flag-Shp1 for 24 h and then treated with TDM for 24 h before 
assessment with the PLA assay. Interaction of endogenous Sirpα with indicated 
proteins were visualized as fluorescent spots (Red, PLA signal), nuclei were 
stained with DAPI (blue), and the number of PLA signals was determined for at 
least 50 cells for each condition. HA-Lyn, Flag-Shp1 and the interactions of 
endogenous (b)Pirb with the indicated target were determined with the PLA assay.
(c-e) Lyn-/-, Sirpa-/-, Syk-/- iBMM cells were transfected with one of 
Flag-CD11b, Flag-Syk, V5-Mincle, HA-Lyn, Flag-Shp1 and the interactions of 
endogenous Sirpa with the indicated target were determined with the PLA assay.
Interactions were visualized as fluorescent spots (Red, PLA signal), nuclei were 
stained with DAPI (blue), the number of PLA signals was determined for at least 
50 cells for each condition and shown at the bottom graphs. ND, not detected. 
Data are representative of three independent experiments. **P<0.01, 
***P<0.0001 (two-tailed unpaired Student’s t-test).
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Figure 15. Interaction of SIRPa with transfected proteins in SIRPa-/-, Lyn-/-, 
and Syk-/- iBMMs.
66
Figure 15. Interaction of SIRPa with transfected proteins in SIRPa-/-, Lyn-/-, 
and Syk-/- iBMMs.
Lyn-/-, SIRPa-/-, and Syk-/- iBMMs were transfected separately with Flag-CD11b, 
Flag-Syk, V5-Mincle, HA-Lyn, and Flag-SHP1, and the interactions between 
endogenous SIRPα and the indicated targets were determined by PLA assay. 
Interactions were visualized as fluorescent spots (red, PLA signal), and nuclei 
were stained with DAPI (blue).
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Figure 16. Sirpa displayed negative role in Mincle signal regulation
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Figure 16. Sirpa displayed negative role in Mincle signal regulation
(a) Sirpa knock out was confirmed by western blot assay (top panel). Culture 
media were collected 24 h after TDM stimulation and subjected to ELISA for 
measurement of IL-6 and TNF-α production (bottom panel). (b) WT and 
Sirpa-deficient iBMMs were stimulated with TDM for the indicated times.
(c)Then the kinase activity of Syk and Erk in cell lysates were determined by 
western blot assay. b-actin protein expression was used as loading control in 
western blot assay. Data are representative of two (a and b) or three  (c) 
independent experiments. *P<0.05, ***P<0.0001 (two-tailed unpaired Student’s 
t-test).                     
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Figure 17. IL-6 production in Mincle-expressing iBMMs, and rescue 
experiments with CD11b-/- and Syk-/- iBMMs.
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Figure 17. IL-6 production in Mincle-expressing iBMMs, and rescue 
experiments with CD11b-/- and Syk-/- iBMMs.
(a) WT iBMMs and iBMMs stably expressing Mincle-V5 were treated with TDM 
for 9 h, and IL-6 production was assayed by ELISA. (b) CD11b-/- iBMMs 
transiently transfected with Flag-CD11b and Syk-/- iBMMs transiently transfected 
with Flag-Syk were stimulated with TDM for 24 h. IL-6 secretion was determined 
by ELISA. Data are representative of three independent experiments.
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Figure 18. Complex formation of CD11b with Mincle upon TDM stimulation
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- continued Figure 18
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- continued Figure 18
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Figure 18. Complex formation of CD11b with Mincle upon TDM stimulation
(a and b) After immunoprecipitation with Mincle in TDM or LPS stimulated 
Mincle stable expression iBMM cells, Mincle-V5, CD11b, Syk and Shp1 were 
assayed with WB (c and d) Immunoprecipitation of endogenous Lyn in WT and 
CD11b-/- BMMs upon TDM stimulation, Shp1, CD11b and Syk were assayed 
with WB at (c) indicated times or (e) 24 h after stimulation. (d and f)
Immunoprecipitation of endogenous Shp1 in WT and CD11b-/- BMMs upon 
TDM stimulation, then Shp1 and Syk were assayed with WB at (e) indicated 
times or (f) 24 h after stimulation.. Data are representative of at least two
independent experiments.
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Figure 19. Lyn activator MLR1023 inhibits TDM signaling both in vivo and 
in vitro.
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- continued Figure 19.
77
- continued Figure 19.
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Figure 19. Lyn activator MLR1023 inhibits TDM signaling both in vivo and 
in vitro.
(a) Production of IL-6 by WT and CD11b-/- BMMs challenged with TDM and (1 
ng/ml) MLR1023 or DMSO for 24 h was assessed by ELISA. (b) Western blot 
assay of Syk and Erk kinase activity and Mincle induction in WT and CD11b-/-
BMMs challenged by TDM and (1 ng/ml) MLR1023 or DMSO for 24 h. b-actin 
protein expression was used as loading control in western blot assay.
Experimental and control group mice (n=8) were intravenously injected with 
(3.75 mg/kg) TDM in an oil-in-water emulsion on Day 0. Then the treatment 
group mice were intraperitoneally injected with MLR1023 (6 mg/kg in PBS) 
every day beginning on Day 1 until the mice were sacrificed 7 d post-TDM 
challenge. The control group mice were injected with 1% DMSO in PBS. (c) 
Lung tissues were isolated and stained with hematoxylin and eosin (H&E) for 
histology analysis after the lung weight index (LWI) (d) was determined. (e) 
Leukocyte subsets were analyzed by flow cytometry with distinct markers for 
monocytes and macrophages (Mo/Ma, CD11b+ Ly6G-), neutrophils (PMN 
CD11b+ Ly6G+), T cells (CD3+), and B cells (CD19+). (f) The lung 
homogenates were analyzed by ELISA for TNF-a and IL-6 production. Data are 
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representative of two independent experiments. (c-f, mean and s.d. of 8 mice per 
group). *P<0.05, **P<0.01 (two-tailed unpaired Student’s t-test).
Figure 20. MLR1032 restrict granulomas response TDM injected CD11b-/-
mice
80
- continued Figure 20.
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Figure 20. MLR1032 restricte granulomas response TDM injected CD11b-/-
mice 
Experimental and control group mice (n=7) were intravenously injected with (2
mg/kg) TDM in an oil-in-water emulsion on Day 0. Then the treatment group 
mice were intraperitoneally injected with MLR1023 (6 mg/kg in PBS) every day 
beginning on Day 1 until the mice were sacrificed 7 d post-TDM challenge. The 
control group mice were injected with 1% DMSO in PBS. (a) Lung tissues were 
isolated and stained with hematoxylin and eosin (H&E) for histology analysis 
after the lung weight index (LWI) was determined. (b) Leukocyte subsets were 
analyzed by flow cytometry with distinct markers for monocytes and 
macrophages (Mo/Ma, CD11b+ Ly6G-), neutrophils (PMN CD11b+ Ly6G+), T 
cells (CD3+), and B cells (CD19+). (c) The lung homogenates were analyzed by 
ELISA for TNF-a and IL-6 production. Data are representative of two
independent experiments. (a-c, mean and s.d. of 7 mice per group). *P<0.05, 
**P<0.01 (two-tailed unpaired Student’s t-test).
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Table 1 List of PCR primers used in this study
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-Continued Table 1
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Abstract in Korean
Lyn-Shipα-Shp1 복합체를 통한 인테그린 CD11b 단백질의
Mincle 신호전달체계 음성적 제어
마이코박테리아 감염 시, 항염증 반응은 면역 시스템의 과도한
반응에 의한 숙주의 조직 손상을 피할 수 있도록 해준다. 하지만, 
아직까지 마이코박테리아에 의한 면역반응을 특이적으로 조절하는
항염증 반응의 조절자에 대해 알려진 것은 거의 없다. 이 연구에서는
인테그린 CD11b 단백질이 마이코박테리아 cord factor 에 의해
증가하는 Mincle 신호에 대한 중요한 음성 제어자라는 것을 처음으로
밝혔다. CD11b 결핍은 마이코박테리아 감염 시 과도한 염증 반응을
일으킨다. 이 때, 마이코박테리아에 의한 Mincle 의 활성화는 Syk 신호
뿐만 아니라 CD11b 신호도 켜지게 하여 Mincle-CD11b 신호
복합체의 형성을 유도한다. 특히, 활성화된 CD11b 단백질은 Lyn, 
Sirpα, 그리고 Shp1 를 불러와서 복합체를 형성하고, Syk 을 탈인산화
시켜 Mincle 에 의한 염증반응을 제어한다. 뿐만 아니라, Lyn 활성제인
MLR-1023 은 효과적으로 Mincle 신호를 억제하는데, 이것은 Lyn 을
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매개로 염증반응 조절의 가능성을 제시하고 있다. 이러한 결과를
통하여, CD11b 가 마이코박테리아 감염에 의한 면역 반응을 세밀하게
조절할 수 있는 새로운 역할이 있음을 밝혔다는 점에서 매우 큰 의의가
있다고 할 수 있다. 
핵심 되는 말 : CD11b, Mincle, Lyn-Sirpα-Shp1 복합체
